- Home
- TGHL vs DXR Comparison
TGHL vs DXR Comparison
Compare TGHL & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TGHL
- DXR
- Stock Information
- Founded
- TGHL 2020
- DXR 1970
- Country
- TGHL Singapore
- DXR United States
- Employees
- TGHL N/A
- DXR N/A
- Industry
- TGHL EDP Services
- DXR Medical/Dental Instruments
- Sector
- TGHL Technology
- DXR Health Care
- Exchange
- TGHL Nasdaq
- DXR Nasdaq
- Market Cap
- TGHL 42.0M
- DXR 46.9M
- IPO Year
- TGHL 2025
- DXR N/A
- Fundamental
- Price
- TGHL $1.64
- DXR $13.50
- Analyst Decision
- TGHL
- DXR Strong Buy
- Analyst Count
- TGHL 0
- DXR 1
- Target Price
- TGHL N/A
- DXR $25.00
- AVG Volume (30 Days)
- TGHL 171.7K
- DXR 5.1K
- Earning Date
- TGHL 01-01-0001
- DXR 01-01-0001
- Dividend Yield
- TGHL N/A
- DXR N/A
- EPS Growth
- TGHL N/A
- DXR 3.46
- EPS
- TGHL N/A
- DXR 0.36
- Revenue
- TGHL $173,668.00
- DXR $66,306.00
- Revenue This Year
- TGHL N/A
- DXR N/A
- Revenue Next Year
- TGHL N/A
- DXR N/A
- P/E Ratio
- TGHL N/A
- DXR $38.30
- Revenue Growth
- TGHL 84.40
- DXR N/A
- 52 Week Low
- TGHL $1.56
- DXR $6.55
- 52 Week High
- TGHL $4.25
- DXR $14.00
- Technical
- Relative Strength Index (RSI)
- TGHL N/A
- DXR 66.65
- Support Level
- TGHL N/A
- DXR $13.39
- Resistance Level
- TGHL N/A
- DXR $14.00
- Average True Range (ATR)
- TGHL 0.00
- DXR 0.50
- MACD
- TGHL 0.00
- DXR 0.13
- Stochastic Oscillator
- TGHL 0.00
- DXR 80.93
About TGHL The GrowHub Limited Class A Ordinary Shares
The Growhub Ltd operates at the intersection of technology and supply chain management in the food industry, focusing on enhancing product traceability and authenticity. With a commitment to innovation and sustainability, It has developed a multi-faceted approach to address industry challenges. its business currently comprises two main divisions, which are the GrowHub Platform and its product trading facilitation offering.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.